| dc.contributor.author | Blandino-Rosano, Manuel | |
| dc.contributor.author | Barbaresso, Rebecca | |
| dc.contributor.author | Jiménez Palomares, Margarita | |
| dc.contributor.author | Bozadjieva, Nadejda | |
| dc.contributor.author | Werneck-de-Castro, Joao Pedro | |
| dc.contributor.author | Hatanaka, Masayuki | |
| dc.contributor.author | Mirmira, Raghavendra | |
| dc.contributor.author | Sonenberg, Nahum | |
| dc.contributor.author | Liu, Ming | |
| dc.contributor.author | Ruegg, Markus A. | |
| dc.contributor.author | Hall, Michael N. | |
| dc.contributor.author | Bernal-Mizrachi, Ernesto | |
| dc.contributor.other | Biomedicina, Biotecnología y Salud Pública | es_ES |
| dc.date.accessioned | 2025-01-26T11:41:43Z | |
| dc.date.available | 2025-01-26T11:41:43Z | |
| dc.date.issued | 2017-07-12 | |
| dc.identifier.issn | 2041-1723 | |
| dc.identifier.uri | http://hdl.handle.net/10498/34812 | |
| dc.description.abstract | Deregulation of mTOR complex 1 (mTORC1) signalling increases the risk for metabolic diseases, including type 2 diabetes. Here we show that beta-cell-specific loss of mTORC1 causes diabetes and beta-cell failure due to defects in proliferation, autophagy, apoptosis and insulin secretion by using mice with conditional (beta raKO) and inducible (MIP-beta raKO(f/f)) raptor deletion. Through genetic reconstitution of mTORC1 downstream targets, we identify mTORC1/S6K pathway as the mechanism by which mTORC1 regulates beta-cell apoptosis, size and autophagy, whereas mTORC1/4E-BP2-eIF4E pathway regulates beta-cell proliferation. Restoration of both pathways partially recovers b-cell mass and hyperglycaemia. This study also demonstrates a central role of mTORC1 in controlling insulin processing by regulating cap-dependent translation of carboxypeptidase E in a 4EBP2/eIF4E-dependent manner. Rapamycin treatment decreases CPE expression and insulin secretion in mice and human islets. We suggest an important role of mTORC1 in beta-cells and identify downstream pathways driving beta-cell mass, function and insulin processing. | es_ES |
| dc.format | application/pdf | es_ES |
| dc.language.iso | eng | es_ES |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.source | Nature Communications, Vol. 8, 2017 | es_ES |
| dc.subject | TRANSGENIC MICE | es_ES |
| dc.subject | IN-VIVO | es_ES |
| dc.subject | AUTOPHAGY REGULATION | es_ES |
| dc.subject | S6 KINASE | es_ES |
| dc.subject | PROINSULIN | es_ES |
| dc.subject | BETA CELL MASS | es_ES |
| dc.subject | BETA CELL FUNCTION | es_ES |
| dc.subject | PHOSPHORYLATION | es_ES |
| dc.subject | DIABETES | es_ES |
| dc.subject | RESISTANCE | es_ES |
| dc.title | Loss of mTORC1 signalling impairs β-cell homeostasis and insulin processing | es_ES |
| dc.type | journal article | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.identifier.doi | 10.1038/ncomms16014 | |
| dc.type.hasVersion | VoR | es_ES |